BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 33053976)

  • 21. Current understanding and future directions in the application of TIMP-2 and IGFBP7 in AKI clinical practice.
    Fan W; Ankawi G; Zhang J; Digvijay K; Giavarina D; Yin Y; Ronco C
    Clin Chem Lab Med; 2019 Apr; 57(5):567-576. PubMed ID: 30179848
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A combined approach for the early recognition of acute kidney injury after adult cardiac surgery.
    Zaouter C; Potvin J; Bats ML; Beauvieux MC; Remy A; Ouattara A
    Anaesth Crit Care Pain Med; 2018 Aug; 37(4):335-341. PubMed ID: 29777769
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Validation of cell-cycle arrest biomarkers for acute kidney injury using clinical adjudication.
    Bihorac A; Chawla LS; Shaw AD; Al-Khafaji A; Davison DL; Demuth GE; Fitzgerald R; Gong MN; Graham DD; Gunnerson K; Heung M; Jortani S; Kleerup E; Koyner JL; Krell K; Letourneau J; Lissauer M; Miner J; Nguyen HB; Ortega LM; Self WH; Sellman R; Shi J; Straseski J; Szalados JE; Wilber ST; Walker MG; Wilson J; Wunderink R; Zimmerman J; Kellum JA
    Am J Respir Crit Care Med; 2014 Apr; 189(8):932-9. PubMed ID: 24559465
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tissue inhibitor metalloproteinase-2 (TIMP-2) • IGF-binding protein-7 (IGFBP7) levels are associated with adverse outcomes in patients in the intensive care unit with acute kidney injury.
    Xie Y; Ankawi G; Yang B; Garzotto F; Passannante A; Breglia A; Digvijay K; Ferrari F; Brendolan A; Raffaele B; Giavarina D; Gregori D; Ronco C
    Kidney Int; 2019 Jun; 95(6):1486-1493. PubMed ID: 30982674
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analysis of urinary C-C motif chemokine ligand 14 (CCL14) and first-generation urinary biomarkers for predicting renal recovery from acute kidney injury: a prospective exploratory study.
    Qian BS; Jia HM; Weng YB; Li XC; Chen CD; Guo FX; Han YZ; Huang LF; Zheng Y; Li WX
    J Intensive Care; 2023 Mar; 11(1):11. PubMed ID: 36941674
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The use of urinary biomarkers to predict acute kidney injury in children after liver transplant.
    Fuhrman DY; Kellum JA; Joyce EL; Miyashita Y; Mazariegos GV; Ganoza A; Squires JE
    Pediatr Transplant; 2020 Feb; 24(1):e13608. PubMed ID: 31652022
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The diagnostic accuracy of urinary [TIMP-2]·[IGFBP7] for acute kidney injury in adults: A PRISMA-compliant meta-analysis.
    Liu C; Lu X; Mao Z; Kang H; Liu H; Pan L; Hu J; Wang L; Zhou F
    Medicine (Baltimore); 2017 Jul; 96(27):e7484. PubMed ID: 28682920
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serial Urinary Tissue Inhibitor of Metalloproteinase-2 and Insulin-Like Growth Factor-Binding Protein 7 and the Prognosis for Acute Kidney Injury over the Course of Critical Illness.
    McCullough PA; Ostermann M; Forni LG; Bihorac A; Koyner JL; Chawla LS; Shi J; Kampf JP; McPherson P; Kellum JA;
    Cardiorenal Med; 2019; 9(6):358-369. PubMed ID: 31618746
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Urinary [TIMP-2]·[IGFBP7]-guided randomized controlled intervention trial to prevent acute kidney injury in the emergency department.
    Schanz M; Wasser C; Allgaeuer S; Schricker S; Dippon J; Alscher MD; Kimmel M
    Nephrol Dial Transplant; 2019 Nov; 34(11):1902-1909. PubMed ID: 29961888
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cell cycle arrest biomarkers for predicting renal recovery from acute kidney injury: a prospective validation study.
    Jia HM; Cheng L; Weng YB; Wang JY; Zheng X; Jiang YJ; Xin X; Guo SY; Chen CD; Guo FX; Han YZ; Zhang TE; Li WX
    Ann Intensive Care; 2022 Feb; 12(1):14. PubMed ID: 35150348
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Urine cell cycle arrest biomarkers distinguish poorly between transient and persistent AKI in early septic shock: a prospective, multicenter study.
    Titeca-Beauport D; Daubin D; Van Vong L; Belliard G; Bruel C; Alaya S; Chaoui K; Andrieu M; Rouquette-Vincenti I; Godde F; Pascal M; Diouf M; Vinsonneau C; Klouche K; Maizel J
    Crit Care; 2020 Jun; 24(1):280. PubMed ID: 32487237
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical adjudication in acute kidney injury studies: findings from the pivotal TIMP-2*IGFBP7 biomarker study.
    Liu KD; Vijayan A; Rosner MH; Shi J; Chawla LS; Kellum JA
    Nephrol Dial Transplant; 2016 Oct; 31(10):1641-6. PubMed ID: 27342580
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic value of cell cycle arrest biomarkers in patients at high risk for acute kidney injury: A systematic review and meta-analysis.
    Jia HM; Huang LF; Zheng Y; Li WX
    Nephrology (Carlton); 2017 Nov; 22(11):831-837. PubMed ID: 28646585
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Value of renal injury marker protein in early diagnosis of acute kidney injury in burn patients with delayed resuscitation].
    Li XL; Ye XY; Li YG; Xiao HT; Zhao XK; Zhang J; Feng K; Tian SM; Lou JH; Xia CD
    Zhonghua Shao Shang Za Zhi; 2021 Feb; 37(2):143-149. PubMed ID: 33550768
    [No Abstract]   [Full Text] [Related]  

  • 35. [Construction of a risk predictive model of acute kidney injury based on urinary tissue inhibitor of metalloproteinase 2 and insulin-like growth factor-binding protein 7 and its early predictive value in critically ill patients].
    Wang H; Mou H; Xu X; Zheng R
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2024 Apr; 36(4):387-391. PubMed ID: 38813633
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reference intervals of urinary acute kidney injury (AKI) markers [IGFBP7]∙[TIMP2] in apparently healthy subjects and chronic comorbid subjects without AKI.
    Chindarkar NS; Chawla LS; Straseski JA; Jortani SA; Uettwiller-Geiger D; Orr RR; Kellum JA; Fitzgerald RL
    Clin Chim Acta; 2016 Jan; 452():32-7. PubMed ID: 26522657
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of patients' clinical features at intensive care unit admission on performance of cell cycle arrest biomarkers in predicting acute kidney injury.
    Yang B; Xie Y; Garzotto F; Ankawi G; Passannante A; Brendolan A; Bonato R; Carta M; Giavarina D; Vidal E; Gregori D; Ronco C
    Clin Chem Lab Med; 2020 Sep; 59(2):333-342. PubMed ID: 32986608
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnostic Value of Urine Tissue Inhibitor of Metalloproteinase-2 and Insulin-Like Growth Factor-Binding Protein 7 for Acute Kidney Injury: A Meta-Analysis.
    Su Y; Gong Z; Wu Y; Tian Y; Liao X
    PLoS One; 2017; 12(1):e0170214. PubMed ID: 28107490
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of biomarkers as predictors of acute kidney injury and mortality in decompensated cirrhosis.
    Jo SK; Yang J; Hwang SM; Lee MS; Park SH
    Sci Rep; 2019 Oct; 9(1):14508. PubMed ID: 31601879
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A promising marker in early diagnosis of septic acute kidney injury of critically ill patients: urine insulin like growth factor binding protein-7.
    Aydoğdu M; Boyacı N; Yüksel S; Gürsel G; Sivri AB
    Scand J Clin Lab Invest; 2016 Sep; 76(5):402-10. PubMed ID: 27240440
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.